ProQR Therapeutics
PRQR
#8589
Rank
NZ$0.41 B
Marketcap
NZ$2.97
Share price
-3.91%
Change (1 day)
-20.88%
Change (1 year)

Earnings for ProQR Therapeutics (PRQR)

Earnings in 2026 (TTM): -NZ$90.82 Million

According to ProQR Therapeutics's latest financial reports the company's current earnings are NZ$15.74 Million. In 2025 the company made an earning of -NZ$84.01 Million a decrease over its 2024 earnings that were of -NZ$51.96 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ProQR Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$90.82 Million8.1%
2025 -NZ$84.01 Million61.68%
2024 -NZ$51.96 Million-0.43%
2023 -NZ$52.19 Million-53.3%
2022 -NZ$0.12 Billion-9.46%
2021 -NZ$0.13 Billion32.43%
2020 -NZ$93.19 Million-14.74%
2019 -NZ$0.11 Billion44.94%
2018 -NZ$75.42 Million-12.86%
2017 -NZ$86.54 Million15.72%
2016 -NZ$74.79 Million87.36%
2015 -NZ$39.92 Million44.86%
2014 -NZ$27.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Atara Biotherapeutics
ATRA
-NZ$10.08 Million-89.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.20 B-324.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Actinium Pharmaceuticals
ATNM
-NZ$44.07 Million-52.06%๐Ÿ‡บ๐Ÿ‡ธ USA